← All Panacea Life Sciences Holdings, INC filings

Panacea Life Sciences Holdings, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink

6 May 2024

PLSH

10-Q: Panacea Life Sciences Holdings Reports Increased Revenue in Q1 2024, Focuses on Nutraceutical Manufacturing

Panacea Life Sciences Holdings saw a 56% increase in revenue for the quarter ended March 31, 2024, driven by growth in nutraceutical contract manufacturing.